Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2000 participants.
Also called NCT06964464
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 2,000 participants
- Registry
-
NCT06964464
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT06964464. Randomized; no masking; primary purpose treatment. Start 2025-08-17 (actual); primary completion 2031-06-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
- Acronym
- CARVTOP-ICD
- Condition
- Sudden Cardiac Death
- Condition
- Ventricular Arrhythmia
- Condition
- Implantable Cardioverter Defibrillator (ICD)
- Condition
- Beta-blocker Therapy
- Condition
- Cardiomyopathy
- Intervention (Drug)
- Metoprolol Succinate
- Intervention (Drug)
- Carvedilol
- Lead sponsor
- University of Rochester
- Collaborator
- Patient-Centered Outcomes Research Institute
Record details
- Record id
cardio:ct-nct06964464- Content hash
ac4da2e09fe8e73bf9715690c3976697a3a1c50d7e9c0701ad8b8207d02eb14a